Assessment of Endocan Serum Levels in Patients With Behcet Disease

NCT03853135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2020-01-06

No results posted yet for this study

Summary

The aim of our study was to assess serum endocan levels in patients with Behcet disease and to correlate it with various disease clinical and laboratory parameters of disease activity as well as carotid intima media thickness.

Conditions

  • Behçet

Interventions

DIAGNOSTIC_TEST

measurement of serum endocan

measurement of serum levels of endocan

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • Waleed Hassan, MD · Benha university- Qaluibya- Egypt

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-27
Primary Completion
2019-12-16
Completion
2019-12-16

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03853135 on ClinicalTrials.gov